OVARIAN CANCER RESEARCH FUND INC: Form 990, tax year 2025
View the entire original 990 at ProPublica ↗
- Organization
- OVARIAN CANCER RESEARCH FUND INC (EIN 13-3806788)
- Tax period
- 2025-01-01 to 2025-12-31
- Filed
- 2026-09-11
- IRS object ID
- 202602549349301565
- Schema version
- 2025v4.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2026-09-11T15:16:17-05:00 | ReturnTs |
| Tax Period End | 2025-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 331374517 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | PKF O'CONNOR DAVIES ADVISORY LLC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 500 MAMARONECK AVENUE SUITE 301 | AddressLine1Txt |
| City | HARRISON | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 105281633 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2025-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 133806788 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | THE OVARIAN CANCER RESEARCH FUND INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | OVAR | BusinessNameControlTxt |
| Phone | 2122681002 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 45 ROCKEFELLER PLAZA 20TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 101113193 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | AUDRA L MORAN | PersonNm |
| Person Title | PRESIDENT & CEO | PersonTitleTxt |
| Phone | 2122681002 | PhoneNum |
| Signature | 2026-09-11 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | MELISSA MODELSON | PreparerPersonNm |
| PTIN | P01603524 | PTIN |
| Phone | 9143818900 | PhoneNum |
| Preparation | 2026-09-10 | PreparationDt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2025 | TaxYr |
Form 990 IRS990
Doing Business As Name DoingBusinessAsName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | OVARIAN CANCER RESEARCH ALLIANCE | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | AUDRA L MORAN | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 45 ROCKEFELLER PLAZA 20TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 101113193 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $25,301,177 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.OCRAHOPE.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1994 | FormationYr |
| Legal Domicile State | NY | LegalDomicileStateCd |
| Activity Or Mission | OVARIAN CANCER RESEARCH ALLIANCE IS COMMITTED TO PREVENTING, DEVELOPING BETTER TREATMENTS FOR AND ULTIMATELY CURING OVARIAN AND RELATED GYNECOLOGIC CANCERS THROUGH INNOVATIVE RESEARCH, RAISING AWARENESS AND ENSURING THE BEST CARE POSSIBLE THROUGH ADVOCACY AND SUPPORT FOR PATIENTS AND FAMILIES. | ActivityOrMissionDesc |
| Voting Members Governing Body | 18 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 18 | VotingMembersIndependentCnt |
| Total Employee | 29 | TotalEmployeeCnt |
| Total Volunteers | 1937 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $8,538,194 | PYContributionsGrantsAmt |
| CY Contributions Grants | $17,855,600 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $301,023 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $1,219,860 | PYInvestmentIncomeAmt |
| CY Investment Income | $1,754,552 | CYInvestmentIncomeAmt |
| PY Other Revenue | -$11,079 | PYOtherRevenueAmt |
| CY Other Revenue | -$77,316 | CYOtherRevenueAmt |
| PY Total Revenue | $10,047,998 | PYTotalRevenueAmt |
| CY Total Revenue | $19,532,836 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $6,428,064 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $8,681,352 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $2,887,953 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $3,741,701 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $1,954,779 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $4,240,499 | PYOtherExpensesAmt |
| CY Other Expenses | $4,915,016 | CYOtherExpensesAmt |
| PY Total Expenses | $13,556,516 | PYTotalExpensesAmt |
| CY Total Expenses | $17,338,069 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$3,508,518 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $2,194,767 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $38,070,603 | TotalAssetsBOYAmt |
| Total Assets EOY | $42,551,929 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $14,914,782 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $15,499,304 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $23,155,821 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $27,052,625 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | OVARIAN CANCER RESEARCH ALLIANCE (OCRA) IS COMMITTED TO PREVENTING, DEVELOPING BETTER TREATMENTS FOR AND ULTIMATELY CURING OVARIAN AND RELATED GYNECOLOGIC CANCERS THROUGH INNOVATIVE RESEARCH, RAISING AWARENESS AND ENSURING THE BEST CARE POSSIBLE THROUGH ADVOCACY AND SUPPORT FOR PATIENTS AND FAMILIES. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $10,447,492 | ExpenseAmt |
| Grant | $8,681,352 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | OVARIAN CANCER RESEARCH ALLIANCE WAS FOUNDED IN 1994 (AS THE OVARIAN CANCER RESEARCH FUND, INC.) AND IS A FULL-SPECTRUM ORGANIZATION FUNDING MEDICAL RESEARCH, ADVOCATING ON BEHALF OF PATIENTS AND PROVIDING SUPPORT AND RESOURCES TO PATIENTS AND THEIR FAMILIES.OVARIAN CANCER IS THE DEADLIEST OF ALL GYNECOLOGIC CANCERS AND RANKS FIFTH AS THE CAUSE OF CANCER DEATH IN WOMEN. IN 2025, THERE WERE 20,890 NEW CASES OF OVARIAN CANCER AND 12,730 DEATHS FROM THE DISEASE IN THE UNITED STATES. THE ACCOMPLISHMENTS OF OCRA'S PROGRAMS REFLECT OUR COMMITMENT TO THE OVARIAN AND GYNECOLOGIC CANCER COMMUNITIES. SINCE 1998, OCRA HAS AWARDED 457 GRANTS FOR OVARIAN AND RELATED CANCER RESEARCH TO PHYSICIANS AND SCIENTISTS AT 103 LEADING MEDICAL CENTERS, WHICH IS AN INVESTMENT TOTALING OVER $137 MILLION. THANKS TO THE GENEROSITY OF OUR DONORS, OUR INVESTIGATORS ARE WORKING ON MANY FRONTS TO DEFEAT OVARIAN CANCER. BY DEVELOPING INNOVATIVE STRATEGIES FOR EARLY DETECTION AND EXPLORING THE GENETICS THAT INCREASE RISK FOR OVARIAN CANCER, WE HOPE TO SAVE WOMEN'S LIVES BY FINDING THE CANCER EARLY OR STOPPING IT BEFORE IT EVEN STARTS. RESEARCHERS ARE GAINING INSIGHTS INTO THE MANY TYPES OF OVARIAN AND RELATED CANCERS TO DETERMINE THE ORIGINS, WHICH MAY LEAD TO MORE EFFECTIVE TESTING AND EFFECTIVE IMMUNOTHERAPY TREATMENT OPTIONS. FURTHERMORE, THEY ARE IDENTIFYING NEW AND BETTER TREATMENTS TO IMPROVE OVERALL SURVIVAL, PREVENT DRUG RESISTANCE, MINIMIZE SIDE EFFECTS, PREVENTING RECURRENCE AND METASTASIS AND ENHANCE PATIENTS' QUALITY OF LIFE. IN ADDITION TO OCRA'S ESTABLISHED RESEACH GRANT PROGRAM, OCRA ALSO CONTINUED THE HEALTH EQUITY RESEARCH GRANTS BEGUN IN 2023. THESE GRANTS FOCUS ON IMPROVING HEALTH EQUITY IN THE GYNECOLOGIC CANCER SPACE. AS PART OF OUR GLOBAL GYNECOLOGIC CANCER CONSORTIUM, MADE UP OF PARTNERS FROM THE UK, AUSTRALIA AND CANADA, OCRA LAUNCHED A NEW AI GRANT IN 2025. THE FIRST GRANT WAS AWARDED IN 2025 WITH A START DATE OF 2026. AND WITH THE RIVKIN CENTER JOINING OCRA IN 2025, THE FORMER RIVKIN PILOT GRANTS WERE ADDED, AS WELL. ACCOMPLISHMENTS ACHIEVED AS A RESULT OF OCRA GRANTS INCLUDE:IDENTIFIED A MOLECULE THAT COULD BE KEY TO IMPROVING IMMUNE RESPONSE AGAINST OVARIAN CANCER; SOUGHT TO UNDERSTAND WHY CERTAIN OVARIAN CANCER CELLS RESIST OLAPARIB TREATMENT, AND DISCOVERED THAT INTRODUCING A SECOND DRUG (MIFEPRISTONE) WHILE TARGETING CERTAIN CELLS (POLYPLOID GIANT CANCER CELLS) MAY OFFER A SOLUTION; IDENTIFIED A PREVIOUSLY UNKNOWN CHEMORESISTANT PATHWAY IN HGSC WHICH LED TO WORKING ON A NEW THERAPY TO OVERCOME THIS; SHED NEW LIGHT ON HOW THE MOST COMMON SUBTYPE OF OVARIAN CANCER DEVELOPS AND METASTASIZES, BY IDENTIFYING A KEY MOLECULE THAT ALLOWS MALIGNANCIES IN THE FALLOPIAN TUBE TO MIGRATE TO THE OVARIES AND CONTINUE TO GROW; UNCOVERED SEVERAL MECHANISMS OF IMMUNE ESCAPE TO HELP EXPLAIN SOME OVARIAN CANCERS' RESISTANCE TO IMMUNOTHERAPY; SHOWED THAT RUCAPARIB EXTENDS PROGRESSION FREE SURVIVAL IN OVARIAN CANCER; DISCOVERED THAT 18% OF OVARIAN CANCER CASES INVOLVE INHERITED MUTATIONS; PINPOINTED TWO GENES THAT TRIGGER OVARIAN CANCER; DEMONSTRATED HOW GENE THERAPY MAY HELP PATIENTS WITH RECURRENT DISEASE; DISCOVERED THAT ANALYZING DATA FROM PAP SMEARS COULD HELP DETECT ENDOMETRIAL AND OVARIAN CANCER; ESTABLISHED THERE IS NO LINK BETWEEN OBESITY AND RISK FOR THE MOST COMMON TYPE OF OVARIAN CANCER; SHOWN THAT FGFR4 IS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET FOR OVARIAN CANCER; DEFINED SIMILARITIES BETWEEN SOME ENDOMETRIAL, BREAST AND OVARIAN CANCERS; EXPLAINED HOW AN EXPERIMENTAL DRUG MAY BE HELPFUL IN FIGHTING PLATINUM-RESISTANT OVARIAN CANCER; IDENTIFIED BIOMARKERS THAT CAN BE USED TO MONITOR THE DEVELOPMENT OF PLATINUM RESISTANCE THERAPIES; IDENTIFIED NOVEL BIOMARKERS OF HGSOC AND SPECIFIC DRUG TARGETS; TARGETED MDM2 DEGRADATION AS A NOVEL TREATMENT FOR OVARIAN CANCER; USED MACHINE LEARNING TO BRIDGE THE GAP BETWEEN DISPARATE DATA SETS SPECIFICALLY IN PATIENTS WITH HGSOC; DOSED THE FIRST PATIENTS IN THE CLINICAL TRIAL "IMMUNOTHERAPY PLATFORM STUDY IN PLATINUM RESISTANT HIGH GRADE SEROUS OVARIAN CANCER (IPROC)" (NCT04918186); FOUND KEY PROTEINS IN HGSOC CANCER CELLS WHICH RESULTED IN COMBINED TREATMENT OPTIONS WHICH RESULTED IN SMALLER TUMORS AND LONGER SURVIVAL; SHOWED HOW SURGICAL REMOVAL OF FALLOPIAN TUBES MAY REDUCE OVARIAN CANCER RISK; UNCOVERED SEVERAL MECHANISMS OF IMMUNE ESCAPE TO HELP EXPLAIN SOME OVARIAN CANCERS' RESISTANCE TO IMMUNOTHERAPY; FOUND A DECREASE IN OVARIAN CARCINOMA INCIDENCE AFTER SALPINGECTOMY FOR TREATING ECTOPIC PREGNANCY; SHOWED PARP1 IS INVOLVED IN REPAIR OF TELOMERES, AND THAT IMPAIRING THIS PROCESS CAN LEAD TO TELOMERE SHORTENING AND GENOMIC INSTABILITY THAT CAN CAUSE CANCER; DEVELOPED A PROOF-OF-CONCEPT STUDY TO SHOW HOW THREE-DIMENSIONAL MODELING CAN SHOW HOW CANCER CELLS AND CAR-T INTERACT WHICH WILL HOPEFULLY LEAD TO BETTER TREATMENTS IN PATIENTS WITH HGSOC SOLID TUMORS; DISCOVERED THAT AGGRESSIVE OVARIAN CANCERS OFTEN SHOW SUDDEN LARGE-SCALE DNA DAMAGE, POINTING TO DISTINCT ORIGINS AND DETECTION STRATEGIES; AND IDENTIFIED THAT LOSS OF A GENE CALLED SMARCA4 MAKES OVARIAN CANCER CELLS MORE VISIBLE TO THE IMMUNE SYSTEM, BOOSTING IMMUNE ATTACK AND SUGGESTING A NEW STRATEGY TO IMPROVE IMMUNOTHERAPY.IN 2025 ALONE, OCRA RESEARCHERS: DEVELOPED A PIONEERING AI TOOL TO BETTER PREDICT TREATMENT RESPONSE, A STEP TOWARD EARLIER PERSONALIZED TREATMENT PLANS; SYSTEMATICALLY TESTED EXISTING THERAPIES TO FIND AN EFFECTIVE DRUG COMBINATION THAT SHOWS PROMISE; UNCOVERED KEY DIFFERENCES IN IMMUNE ENVIRONMENTS BETWEEN PRIMARY TUMORS AND METASTASES THAT MAY EXPLAIN WHY HIGH-GRADE SEROUS OVARIAN CARCINOMA OFTEN SUPPRESSES THE IMMUNE SYSTEM; FOUND THAT MUCINOUS OVARIAN CANCERS WITH KEY GENE CHANGES WERE ASSOCIATED WITH WORSE SURVIVAL EVEN AT EARLY STAGES, SUGGESTING GENETIC TESTING AT DIAGNOSIS MAY HELP GUIDE CARE AND PREDICT OUTCOMES; DISCOVERED THAT BLOCKING A KEY NUTRIENT WHILE ALSO USING IMMUNOTHERAPY COULD OFFER A PROMISING NEW TREATMENT STRATEGY FOR AROUND HALF OF OVARIAN CLEAR CELL CANCERS; FOUND THAT AMONG PEOPLE DIAGNOSED WITH AN EARLY OVARIAN CANCER PRECURSOR, OLDER PATIENTS AND BLACK PATIENTS FACE WORSE SURVIVAL, UNDERSCORING THE URGENT NEED FOR MORE TAILORED CARE AND TREATMENT STRATEGIES; FOUND THAT PROBIOTIC SUPPLEMENTS MAY HELP GYNECOLOGIC CANCER PATIENTS REDUCE RADIATION-RELATED GUT SIDE EFFECTS; FOUND THAT A SPECIFIC DNA-REPAIR PROTEIN HELPS CANCER CELLS GROW BY SWITCHING ON A GROWTH PATHWAY, HINTING AT A POTENTIAL TREATMENT TARGET TO MAKE TUMORS MORE TREATABLE WHILE SPARING HEALTHY CELLS; FOUND THAT ENGINEERED IMMUNE CELLS WORKED MUCH BETTER IN COMBINATION WITH THREE IMMUNOTHERAPIES, ALLOWING THE IMMUNE CELLS TO STAY ACTIVE LONGER AND KILL OVARIAN CANCER IN MICE MORE EFFECTIVELY; SHOWED THAT OVARIAN CANCER RECURRENCE IS DRIVEN BY A SMALL NUMBER OF PRE-EXISTING, TREATMENT-RESISTANT CANCER CELL CLONES WHICH ARE DETECTABLE THROUGH A NEW BLOOD TEST THAT MAY PAVE THE WAY TO PREVENTING RECURRENCE; FOUND THAT SPECIALLY ENGINEERED T CELLS THAT SECRETE "BITE" MOLECULES, WHEN COMBINED WITH OTHER IMMUNOTHERAPIES, CAN TRIGGER STRONG AND LASTING ANTI-TUMOR IMMUNE RESPONSES AGAINST OVARIAN CANCER IN MICE; FOUND A WAY TO REPROGRAM MACROPHAGES TO MAKE THE IMMUNE SYSTEM FIGHT THE CANCER AGAIN; DISCOVERED A WAY TO SELECTIVELY REMOVE CERTAIN "PRO-CANCER" IMMUNE CELLS IN OVARIAN TUMORS BY TARGETING A SPECIFIC POCKET ON THE RETINOBLASTOMA (RB) PROTEIN, WHICH HELPS THE IMMUNE SYSTEM FIGHT THE CANCER MORE EFFECTIVELY; CREATED THE FIRST STANDARDIZED SET OF GUIDELINES, TOOLS, AND REFERENCE DATASETS FOR SPATIAL TRANSCRIPTOMICS EXPERIMENTS TO HELP SCIENTISTS COMPARE RESULTS ACROSS LABS AND MEASURE THE QUALITY AND RELIABILITY; UNCOVERED THE RULES THAT GUIDE IMMUNE CELL SIGNALING AND USED THIS KNOWLEDGE TO PROVIDE A WEB RESOURCE TO FACILITATE PROTEIN DESIGN EFFORTS, WHICH CAN BE USED TO DEVELOP NEW IMMUNE-BASED THERAPIES.EVERY DOLLAR DONATED BRINGS US CLOSER TO A CURE FOR THIS DEVASTATING DISEASE. FOR MORE INFORMATION OR TO JOIN US IN OUR FIGHT, PLEASE VISIT OCRA'S WEBSITE AT WWW.OCRAHOPE.ORG. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $3,162,885 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | IN 2025, OVARIAN CANCER RESEARCH ALLIANCE (OCRA) PROVIDED COMPREHENSIVE EDUCATION, SUPPORT, AND NAVIGATION SERVICES TO THOUSANDS OF INDIVIDUALS AFFECTED BY OVARIAN AND GYNECOLOGIC CANCERS. OCRA'S PATIENT SUPPORT TEAM RESPONDED TO 4,237 PATIENT AND CAREGIVER CONTACTS THROUGH OUR PATIENT SUPPORT LINE, A 68% INCREASE FROM 2024, PROVIDING EMOTIONAL SUPPORT, INFORMATION, CLINICAL TRIAL GUIDANCE, PEER MENTORING, AND CARE NAVIGATION. OCRA'S WOMAN TO WOMAN PEER MENTOR PROGRAM CONTINUED TO CONNECT NEWLY DIAGNOSED PATIENTS WITH TRAINED SURVIVOR MENTORS THROUGH 19 ACTIVE SITES NATIONWIDE AND A NATIONAL VIRTUAL MATCHING PROGRAM. SINCE ITS LAUNCH, THE PROGRAM HAS FACILITATED MORE THAN 2,800 MENTOR MATCHES. IN 2025, THE NATIONAL TEAM COMPLETED 103 MATCHES AND SUPPORTED 167 MENTORS. OCRA ALSO PROVIDED INDIVIDUALIZED COUNSELING THROUGH ITS STEPS 1:1 COUNSELING PROGRAM AND FACILITATED ONGOING SUPPORT THROUGH STAYING CONNECTED, WHICH ENGAGED 3,530 PARTICIPANTS IN VIRTUAL SUPPORT AND EXPRESSIVE ARTS PROGRAM DURING THE YEAR. TO ADDRESS THE EDUCATIONAL NEEDS OF PATIENTS AND CAREGIVERS, OCRA DELIVERED ITS INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE, WEBINARS, WORKSHOPS, ROUNDTABLES, AND MONTHLY EDUCATIONAL PROGRAMS FOCUSED ON DIAGNOSIS, TREATMENT ADVANCES, SURVIVORSHIP, BIOMARKER TESTING, AND CLINICAL TRIALS. OFFERED FREE OF CHARGE FOR THE FIRST TIME, OCRA'S INTERNATIONAL GYNECOLOGIC CANCER CONFERENCE EXPANDED ITS REACH TO MORE THAN 2,100 PARTICIPANTS WORLDWIDE. NEARLY 300 INDIVIDUALS PARTICIPATED IN OCRA'S EDUCATIONAL WORKSHOPS, INCLUDING OVARIAN CANCER 101, ENDOMETRIAL/UTERINE CANCER 101, AND SURVIVORSHIP SERIES, WHILE NATIONAL WEBINARS REACHED ALMOST 900 PARTICIPANTS. OCRA'S NEW STAYING CURRENT EDUCATIONAL SERIES PROVIDED DISEASE-SPECIFIC UPDATES AND CLINICAL TRIAL INFORMATION TO MORE THAN 200 PARTICIPANTS. COLLECTIVELY, OCRA'S EDUCATIONAL PROGRAMS REACHED MORE THAN 4,000 PARTICIPANTS IN 2025, PROVIDING TIMELY, EVIDENCE-BASED INFORMATION TO HELP PATIENTS AND CAREGIVERS MAKE INFORMED DECISIONS THROUGHOUT THEIR CANCER JOURNEY.IN ADDITION TO ITS SUPPORT AND EDUCATION PROGRAMS, OCRA OFFERS FREE GENETIC TESTING TO QUALIFIED HIGH-RISK INDIVIDUALS AND FACILITATES ACCESSS TO CERTIFIED GENETIC COUNSELORS. SINCE THE PROGRAM'S INCEPTION, OCRA HAS HELPED MORE THAN 3,000 INDIVIDUALS BETTER UNDERSTAND THEIR INHERITED RISK FOR OVARIAN AND OTHER GYNECOLOGIC CANCERS, EMPOWERING THEM AND THEIR FAMILIES TO MAKE INFORMED HEALTHCARE DECISIONS. ADDITIONALLY, OCRA'S CLINICAL TRIAL NAVIGATOR CONTINUED TO EXPAND ACCESS TO CLINICAL TRIAL INFORMATION, WITH 1,540 COMPLETED QUESTIONNAIRES AND MORE THAN 11,700 WEBSITE VISITS IN 2025.OCRA IS ALSO COMMITTED TO DEVELOPING THE NEXT GENERATION OF HEALTHCARE PROFESSIONALS DEDICATED TO IMPROVING OUTCOMES FOR INDIVIDUALS DIAGNOSED WITH GYNECOLOGIC CANCERS. THROUGH OCRA'S ONCOLOGY SOCIAL WORK FIELD PLACEMENT PROGRAM, MASTER OF SOCIAL WORK CANDIDATES RECEIVE SPECIALIZED TRAINING AND SUPERVISION FROM LICENSED CLINICAL SOCIAL WORKERS, GAINING EXPERIENCE ADDRESSING THE UNIQUE PSYCHOLOGICAL, EMOTIONAL, AND PRACTICAL NEEDS OF PATIENTS AND CAREGIVERS AFFECTED BY GYNECOLOGIC CANCERS.OCRA'S SURVIVORS TEACHING STUDENTS (STS) PROGRAM TRAINS OVARIAN CANCER SURVIVORS AND CAREGIVERS TO CONDUCT PRESENTATIONS IN MEDICAL EDUCATION PROGRAMS TO EDUCATE FUTURE HEALTHCARE PROVIDERS ABOUT OVARIAN CANCER. SURVIVORS SHARE THEIR STORIES OF DIAGNOSIS, TREATMENT AND BEYOND, ALONG WITH FACTS ABOUT THE DISEASE. IN 2025, MORE THAN 930 SURVIVOR VOLUNTEERS DELIVERED MORE THAN 400 PRESENTATIONS IN THE US, UK, AND AUSTRALIA REACHING OVER 10,627 MEDICAL, NURSING, AND PHYSICIAN'S ASSISTANT STUDENTS. THESE PRESENTATIONS ENSURE THE NEXT GENERATION OF HEALTH CARE PROVIDERS UNDERSTAND BASIC FACTS ABOUT THE DISEASE, ARE AWARE OF RISK FACTORS, AND CAN IDENTIFY THE SIGNS AND SYMPTOMS OF OVARIAN CANCER, HELPING ENSURE A TIMELY DIAGNOSIS.THROUGH THESE PROGRAMS, OCRA EMPOWERS PATIENTS AND CAREGIVERS WITH TRUSTED INFORMATION, EMOTIONAL SUPPORT, AND CONNECTIONS TO RESOURCES THAT IMPROVE QUALITY OF LIFE AND INFORMED DECISION-MAKING FROM DIAGNOSIS THROUGH SURVIVORSHIP AND BEYOND. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $595,806 | ExpenseAmt |
| Grant | $0 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | OVARIAN CANCER RESEARCH ALLIANCE IS A POWERFUL VOICE ON CAPITOL HILL, IN STATEHOUSES AROUND THE COUNTRY AND WITH FEDERAL AGENCIES FOR EVERYONE TOUCHED BY GYNECOLOGIC CANCER. IN 2025, OCRA ESTABLISHED ITS CENTER FOR PUBLIC POLICY TO EXPAND POLICY EDUCATION, LEGISLATIVE TRACKING, AND ADVOCACY ENGAGEMENT OPPORTUNITIES FOR PATIENTS, CAREGIVERS, AND SUPPORTERS NATIONWIDE. OCRA TRAINED AND MOBILIZED MORE THAN 160 ADVOCATES AND SUPPORTERS TO ENGAGE IN THE POLICYMAKING PROCESS. NEARLY 120 ADVOCATES FROM 35 STATES AND THE DISTRICT OF COLUMBIA PARTICIPATED IN OCRA'S ADVOCACY DAY, CONDUCTING MORE THAN 135 MEETINGS WITH CONGRESSIONAL OFFICES. THROUGH 12 GRASSROOTS ACTION ALERTS, ADVOCATES GENERATED MORE THAN 21,000 MESSAGES TO POLICYMAKERS, AND MORE THAN 6,000 NEW ADVOCATES JOINED OCRA'S ADVOCACY NETWORK. OCRA'S ADVOCACY CONTRIBUTED TO PRESERVING FEDERAL FUNDING FOR OVARIAN CANCER RESEARCH AND EDUCATION PROGRAMS, SUPPORTED ENACTMENT OF STATE BIOMARKER ACCESS LAWS, SECURED BIPARTISAN CONGRESSIONAL SUPPORT FOR INCREASED OVARIAN CANCER RESEARCH FUNDING, AND HELPED OBTAIN MORE THAN 120 PROCLAMATIONS AND RESOLUTIONS RECOGNIZING OVARIAN CANCER AWARENESS MONTH. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $14,206,183 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | 0 | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (1) | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | Yes (1) | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (1) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | 0 | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 80 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Employee | 29 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | 0 | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 18 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 18 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Other Website | Yes (X) | OtherWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AUDRA L MORAN | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 2122681002 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 45 ROCKEFELLER PLAZA 20TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 101113193 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (30 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd | Former Ofcr Director TrusteeFormerOfcrDirectorTrusteeInd |
|---|---|---|---|---|---|---|---|---|---|---|
| JOHN ORRICO | ||||||||||
| CHAIR | 3.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| MATTHEW NEAL MILLER | ||||||||||
| VICE PRESIDENT | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| MARK TESSAR | ||||||||||
| TREASURER | 2.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| ROBIN S COHEN | ||||||||||
| SECRETARY | 2.00 | 0.10 | Yes (X) | Yes (X) | $0 | $0 | $0 | |||
| DEBRA BIRNBAUM | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| JEANNETTE CHANG | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| CARMEL J COHEN MD | ||||||||||
| DIRECTOR THRU AUG 2025 | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| ANDREW FEUERSTEIN ESQ | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| CAROL J HAMILTON | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| JOHN W HANSBURY ESQ | ||||||||||
| DIRECTOR | 1.00 | 0.10 | Yes (X) | $0 | $0 | $0 | ||||
| CAROLINE HIRSCH | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| VERONICA JORDAN | ||||||||||
| DIRECTOR THRU SEPT 2025 | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| THOMAS C LIEBMAN | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| DANA L MARK ESQ | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| CHRIS NEWCOMB | ||||||||||
| DIRECTOR THRU DEC 2025 | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| MELISSA RIVKIN | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| LISA SCHREIBER | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| LAURA SHAWVER | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| MEI-LI DA SILVA VINT ESQ | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| ELLE SIMONE SCOTT | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| CHRISTOPHER TILBERIS | ||||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | ||||
| AUDRA L MORAN | ||||||||||
| PRESIDENT & CEO | 40.00 | 0.10 | Yes (X) | $333,548 | $0 | $35,207 | ||||
| JONATHAN ZEIDMAN | ||||||||||
| CHIEF DEVELOPMENT OFFICER | 40.00 | 0.00 | $201,949 | $0 | $43,479 | Yes (X) | ||||
| SARAH C DEFEO | ||||||||||
| CHIEF PROGRAM OFFICER | 40.00 | 0.00 | $171,149 | $0 | $69,876 | Yes (X) | ||||
| TRACY MOORE | ||||||||||
| VICE PRESIDENT, SUPPORT & EDUCATION | 40.00 | 0.00 | $162,573 | $0 | $28,215 | Yes (X) | ||||
| ANNE METTE HERTZ SR DIR | ||||||||||
| TREATMENT ACCESS & SCIENTIFIC EDUCATION | 40.00 | 0.00 | $145,000 | $0 | $4,085 | Yes (X) | ||||
| CHAD RAMSEY | ||||||||||
| VICE PRESIDENT, POLICY | 40.00 | 0.00 | $126,974 | $0 | $26,691 | Yes (X) | ||||
| JESSICA HUGHSON ANDRADE | ||||||||||
| SENIOR DIRECTOR, STRATEGIC ALLIANCE | 40.00 | 0.00 | $111,935 | $0 | $24,237 | Yes (X) | ||||
| NICOLE WARGO | ||||||||||
| VP - PHILANTHROPIC PARTNER | 40.00 | 0.00 | $109,257 | $0 | $64,705 | Yes (X) | ||||
| BIBI ALI | ||||||||||
| FORMER CHIEF FINANCIAL OFFICER | 0.00 | 0.00 | $157,000 | $0 | $0 | Yes (X) | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $1,519,385 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $296,495 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 13 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | Yes (1) | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| CIRRO BIO INC | |||||
| 225 SOUTH KING STREET SUITE 800 | SEATTLE | WA | 98104 | DATA SUPPORT SERVICES | $450,000 |
| COSGROVE ACCOUNTING | |||||
| 11161 EAST STATE ROAD 70 SUITE 110 | LAKEWOOD RANCH | FL | 34202 | ACCOUNTING SERVICES | $233,127 |
| COLOR HEALTH | |||||
| 831 MITTEN ROAD SUITE 100 | BURLINGAME | CA | 94010 | HEREDITARY TESTING | $225,489 |
| ADC STRATEGIC COMMUNICATIONS | |||||
| 14 KNOB HILL | PUTNAM VALLEY | NY | 10579 | MARKETING & COMMUNICATION SERVICES | $220,766 |
| AMPLIFI | |||||
| 600 RYERSON ROAD SUITE G | LINCOLN PARK | NJ | 07035 | MAILING SERVICES | $190,045 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 9 | CntrctRcvdGreaterThan100KCnt |
| Fundraising | $458,850 | FundraisingAmt |
| All Other Contributions | $17,396,750 | AllOtherContributionsAmt |
| Noncash Contributions | $1,141,580 | NoncashContributionsAmt |
| Total Contributions | $17,855,600 | TotalContributionsAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $1,068,907 | TotalRevenueColumnAmt |
| Exclusion | $1,068,907 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $6,341,544 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $5,655,899 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $685,645 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $685,645 | TotalRevenueColumnAmt |
| Exclusion | $685,645 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $0 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $458,850 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $112,442 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$112,442 | TotalRevenueColumnAmt |
| Exclusion | -$112,442 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt |
|---|---|---|---|
| INSURANCE PROCEEDS | 900099 | $35,000 | $35,000 |
| OTHER INCOME | 900099 | $126 | $126 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $35,126 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $19,532,836 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $0 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $1,677,236 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $7,888,202 | TotalAmt |
| Program Services | $7,888,202 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $793,150 | TotalAmt |
| Program Services | $793,150 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $855,208 | TotalAmt |
| Program Services | $532,680 | ProgramServicesAmt |
| Management And General | $61,843 | ManagementAndGeneralAmt |
| Fundraising | $260,685 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $157,000 | TotalAmt |
| Management And General | $157,000 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,067,817 | TotalAmt |
| Program Services | $1,418,885 | ProgramServicesAmt |
| Management And General | $64,833 | ManagementAndGeneralAmt |
| Fundraising | $584,099 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $54,256 | TotalAmt |
| Program Services | $29,791 | ProgramServicesAmt |
| Management And General | $5,657 | ManagementAndGeneralAmt |
| Fundraising | $18,808 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $391,462 | TotalAmt |
| Program Services | $249,689 | ProgramServicesAmt |
| Management And General | $38,245 | ManagementAndGeneralAmt |
| Fundraising | $103,528 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $215,958 | TotalAmt |
| Program Services | $136,655 | ProgramServicesAmt |
| Management And General | $20,065 | ManagementAndGeneralAmt |
| Fundraising | $59,238 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $124,939 | TotalAmt |
| Program Services | $42,766 | ProgramServicesAmt |
| Management And General | $76,648 | ManagementAndGeneralAmt |
| Fundraising | $5,525 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $304,507 | TotalAmt |
| Management And General | $304,507 | ManagementAndGeneralAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,000 | TotalAmt |
| Program Services | $9,000 | ProgramServicesAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $87,365 | TotalAmt |
| Management And General | $87,365 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,501,720 | TotalAmt |
| Program Services | $1,207,117 | ProgramServicesAmt |
| Management And General | $213,272 | ManagementAndGeneralAmt |
| Fundraising | $81,331 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $476,124 | TotalAmt |
| Program Services | $396,611 | ProgramServicesAmt |
| Management And General | $1,441 | ManagementAndGeneralAmt |
| Fundraising | $78,072 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $805,711 | TotalAmt |
| Program Services | $297,041 | ProgramServicesAmt |
| Management And General | $81,578 | ManagementAndGeneralAmt |
| Fundraising | $427,092 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $895,459 | TotalAmt |
| Program Services | $605,873 | ProgramServicesAmt |
| Management And General | $44,594 | ManagementAndGeneralAmt |
| Fundraising | $244,992 | FundraisingAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $68,238 | TotalAmt |
| Program Services | $43,180 | ProgramServicesAmt |
| Management And General | $6,340 | ManagementAndGeneralAmt |
| Fundraising | $18,718 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $183,739 | TotalAmt |
| Program Services | $167,510 | ProgramServicesAmt |
| Management And General | $1,433 | ManagementAndGeneralAmt |
| Fundraising | $14,796 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $150,636 | TotalAmt |
| Program Services | $113,394 | ProgramServicesAmt |
| Management And General | $691 | ManagementAndGeneralAmt |
| Fundraising | $36,551 | FundraisingAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $30,000 | TotalAmt |
| Program Services | $18,984 | ProgramServicesAmt |
| Management And General | $2,787 | ManagementAndGeneralAmt |
| Fundraising | $8,229 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $41,968 | TotalAmt |
| Program Services | $26,557 | ProgramServicesAmt |
| Management And General | $3,899 | ManagementAndGeneralAmt |
| Fundraising | $11,512 | FundraisingAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| GENETIC TESTING | $225,489 | $225,489 | ||
| REPAIRS AND MAINTENANCE | $4,366 | $4,366 | ||
| EMPLOYEE EVENTS AND REC | $4,296 | $2,693 | $1,603 | |
| OTHER OPERATING EXPENSE | $1,459 | $916 | $543 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $17,338,069 | TotalAmt |
| Program Services | $14,206,183 | ProgramServicesAmt |
| Management And General | $1,177,107 | ManagementAndGeneralAmt |
| Fundraising | $1,954,779 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,107,359 | BOYAmt |
| EOY | $2,710,809 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,049,345 | BOYAmt |
| EOY | $2,711,451 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,212,071 | BOYAmt |
| EOY | $434,380 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $69,269 | BOYAmt |
| EOY | $149,863 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $313,290 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $263,290 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $80,000 | BOYAmt |
| EOY | $50,000 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $33,033,627 | BOYAmt |
| EOY | $36,071,656 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $518,932 | BOYAmt |
| EOY | $423,770 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $38,070,603 | BOYAmt |
| EOY | $42,551,929 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $361,274 | BOYAmt |
| EOY | $264,987 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,132,020 | BOYAmt |
| EOY | $14,759,507 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $100,000 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $421,488 | BOYAmt |
| EOY | $374,810 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $14,914,782 | BOYAmt |
| EOY | $15,499,304 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $10,207,440 | BOYAmt |
| EOY | $10,569,811 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $12,948,381 | BOYAmt |
| EOY | $16,482,814 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $23,155,821 | BOYAmt |
| EOY | $27,052,625 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $38,070,603 | BOYAmt |
| EOY | $42,551,929 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $2,194,767 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $1,439,645 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | $262,392 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | 0 | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $11,263,534 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $15,386,443 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $11,556,311 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $8,538,194 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $17,855,600 | CurrentTaxYearAmt |
| Total | $64,600,082 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $11,263,534 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $15,386,443 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $11,556,311 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $8,538,194 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $17,855,600 | CurrentTaxYearAmt |
| Total | $64,600,082 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $11,342,652 | SubstantialContributorsTotAmt |
| Public Support Total170 | $53,257,430 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $542,131 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $710,226 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,095,100 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $992,906 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $1,068,907 | CurrentTaxYearAmt |
| Total | $4,409,270 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year | $35,126 | CurrentTaxYearAmt |
| Total | $35,126 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $69,044,478 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $1,334,959 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.77130 | PublicSupportCY170Pct |
| Public Support PY170 | 0.75530 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
Total Grassroots Lobbying TotalGrassrootsLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $5,498 | FilingOrganizationsTotalAmt |
Total Direct Lobbying TotalDirectLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $11,461 | FilingOrganizationsTotalAmt |
Total Lobbying Expend TotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $16,959 | FilingOrganizationsTotalAmt |
Other Exempt Purpose Expend OtherExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $15,278,966 | FilingOrganizationsTotalAmt |
Total Exempt Purpose Expend TotalExemptPurposeExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $15,295,925 | FilingOrganizationsTotalAmt |
Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $914,796 | FilingOrganizationsTotalAmt |
Grassroots Nontaxable GrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $228,699 | FilingOrganizationsTotalAmt |
Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Filing Organizations Total | $0 | FilingOrganizationsTotalAmt |
Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $723,133 | CurrentYearMinus3Amt |
| Current Year Minus2 | $837,638 | CurrentYearMinus2Amt |
| Current Year Minus1 | $751,838 | CurrentYearMinus1Amt |
| Current Year | $914,796 | CurrentYearAmt |
| Total | $3,227,405 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Lobbying Ceiling | $4,841,108 | LobbyingCeilingAmt |
Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $0 | CurrentYearMinus3Amt |
| Current Year Minus2 | $0 | CurrentYearMinus2Amt |
| Current Year Minus1 | $22,395 | CurrentYearMinus1Amt |
| Current Year | $16,959 | CurrentYearAmt |
| Total | $39,354 | TotalAmt |
Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $180,783 | CurrentYearMinus3Amt |
| Current Year Minus2 | $209,410 | CurrentYearMinus2Amt |
| Current Year Minus1 | $187,960 | CurrentYearMinus1Amt |
| Current Year | $228,699 | CurrentYearAmt |
| Total | $806,852 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grassroots Ceiling | $1,210,278 | GrassrootsCeilingAmt |
Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Year Minus3 | $0 | CurrentYearMinus3Amt |
| Current Year Minus2 | $0 | CurrentYearMinus2Amt |
| Current Year Minus1 | $7,500 | CurrentYearMinus1Amt |
| Current Year | $5,498 | CurrentYearAmt |
| Total | $12,998 | TotalAmt |
Schedule D IRS990ScheduleD
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $115,471 | OtherCostOrOtherBasisAmt |
| Depreciation | $115,471 | DepreciationAmt |
| Book Value | $0 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $197,819 | OtherCostOrOtherBasisAmt |
| Depreciation | $147,819 | DepreciationAmt |
| Book Value | $50,000 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $50,000 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | LEASE LIABILITY | Desc |
| Amt | $374,810 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $374,810 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $21,581,159 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $1,439,645 | NetUnrealizedGainsInvstAmt |
| Donated Services And Use Fclts | $583,601 | DonatedServicesAndUseFcltsAmt |
| Other Revenue | $112,442 | OtherRevenueAmt |
| Revenue Not Reported | $2,135,688 | RevenueNotReportedAmt |
| Revenue Subtotal | $19,445,471 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $87,365 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $87,365 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $19,532,836 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $17,684,355 | TotExpnsEtcAuditedFinclStmtAmt |
| Donated Services Use Fclts | $583,601 | DonatedServicesUseFcltsAmt |
| Other Expenses Included | $112,442 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $696,043 | ExpensesNotReportedAmt |
| Expenses Subtotal | $16,988,312 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $87,365 | InvestmentExpensesNotIncld2Amt |
| Other Expenses Not Included | $262,392 | OtherExpensesNotIncludedAmt |
| Expenses Not Rpt Fincl Stmt | $349,757 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $17,338,069 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART X, LINE 2: | OCRA RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BE SUSTAINED. MANAGEMENT HAS DETERMINED THAT OCRA HAD NO UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE FINANCIAL STATEMENT RECOGNITION OR DISCLOSURE. OCRA IS NO LONGER SUBJECT TO EXAMINATIONS BY THE APPLICABLE TAXING JURISDICTIONS FOR YEARS PRIOR TO DECEMBER 31, 2022. |
| PART XI, LINE 2D - OTHER ADJUSTMENTS: | FUNDRAISING EVENT EXPENSES REPORTED ON PART VIII 112,442. |
| PART XII, LINE 2D - OTHER ADJUSTMENTS: | FUNDRAISING EVENT EXPENSES REPORTED ON PART VIII 112,442. |
| PART XII, LINE 4B - OTHER ADJUSTMENTS: | GRANT REFUNDS 262,392. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | NORTH AMERICA | RegionTxt |
| Offices | 0 | OfficesCnt |
| Employee | 0 | EmployeeCnt |
| Type Of Activities Conducted | GRANTMAKING | TypeOfActivitiesConductedTxt |
| Region Total Expenditures | $793,150 | RegionTotalExpendituresAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $793,150 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $793,150 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Region | NORTH AMERICA | RegionTxt |
| Purpose Of Grant | RESEARCH | PurposeOfGrantTxt |
| Cash Grant | $793,150 | CashGrantAmt |
| Manner Of Cash Disbursement | WIRE | MannerOfCashDisbursementTxt |
| Non Cash Assistance | $0 | NonCashAssistanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 1 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | 0 | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 2: | OCRA MONITORS THE USE OF GRANT FUNDS BY REQUIRING ALL GRANTEES TO SUBMIT YEARLY FINANCIAL AND NARRATIVE PROGRESS REPORTS DETAILING THE USE OF FUNDS AND PROGRAM OUTCOMES. THESE REPORTS ARE REVIEWED BY OCRA TO CONFIRM COMPLIANCE WITH THE STATED CHARITABLE OBJECTIVES. |
| PART I, LINE 3: | THE ORGANIZATION USED THE ACCRUAL METHOD OF ACCOUNTING TO ACCOUNT FOR EXPENDITURES. |
Schedule G IRS990ScheduleG
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | SUMMERUN | Event1Nm |
| Gross Receipts Event1 | $332,429 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $332,429 | CharitableContriEvent1Amt |
| Other Direct Expenses Event1 | $100,874 | OtherDirectExpensesEvent1Amt |
| Event2 | OVARIAN CYCLE & FITNESS | Event2Nm |
| Gross Receipts Event2 | $126,421 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $126,421 | CharitableContriEvent2Amt |
| Other Direct Expenses Event2 | $11,568 | OtherDirectExpensesEvent2Amt |
| Gross Receipts Total | $458,850 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $458,850 | CharitableContributionsTotAmt |
| Oth Direct Expnss Total Events | $112,442 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $112,442 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$112,442 | NetIncomeSummaryAmt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (18 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|
| ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | |||||||||
| ONE GUSTAVE L LEVY PLACE | NEW YORK | NY | 10029 | 136171197 | 501(C)(3) | $1,948,941 | $0 | RESEARCH | |
| THE UNIVERSITY OF NEW MEXICO | |||||||||
| 1700 LOMAS BOULEVARD NORTHEAST | ALBUQUERQUE | NM | 87106 | 856000642 | STATE OF NM | $900,000 | $0 | RESEARCH | |
| CORNELL UNIVERSITY | |||||||||
| WILLARD STRAIGHT HALL MAILBOX 86 | ITHACA | NY | 14853 | 150532082 | 501(C)(3) | $900,000 | $0 | RESEARCH | |
| ROSELL PARK CANCER INSTITUTE | |||||||||
| ELM AND CARLTON STREETS | BUFFALO | NY | 14263 | 161391608 | 501(C)(3) | $899,997 | $0 | RESEARCH | |
| MEMORIAL SLOAN KETTERING CANCER CENTER | |||||||||
| 1275 YORK AVENUE | NEW YORK | NY | 10065 | 131924236 | 501(C)(3) | $650,000 | $0 | RESEARCH | |
| MASSACHUSETTS GENERAL HOSPITAL | |||||||||
| 399 REVOLUTION DRIVE NO 645 | SOMERVILLE | MA | 02145 | 042697983 | 501(C)(3) | $450,000 | $0 | RESEARCH | |
| SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE | |||||||||
| 10901 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 510197108 | 501(C)(3) | $450,000 | $0 | RESEARCH | |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES | |||||||||
| MEDICAL CENTER BOULEVARD | WINSTONSALEM | NC | 27157 | 223849199 | 501(C)(3) | $450,000 | $0 | RESEARCH | |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | |||||||||
| 104 AIRPORT DRIVE CB1270 | CHAPEL HILL | NC | 27599 | 566001393 | STATE OF NC | $271,901 | $0 | RESEARCH | |
| EMORY UNIVERSITY | |||||||||
| 1599 CLIFTON ROAD THIRD FLOOR 3101 | ATLANTA | GA | 30322 | 580566256 | 501(C)(3) | $194,950 | $0 | RESEARCH | |
| DANA-FARBER CANCER INSTITUTE | |||||||||
| 450 BROOKLINE AVENUE BP418 | BOSTON | MA | 02215 | 042263040 | 501(C)(3) | $100,000 | $0 | RESEARCH | |
| FRED HUTCHINSON CANCER CENTER | |||||||||
| 1100 FAIRVIEW AVENUE NORTH | SEATTLE | WA | 98109 | 911935159 | 501(C)(3) | $100,000 | $0 | RESEARCH | |
| THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY | |||||||||
| 3601 SPRUCE STRET | PHILADELPHIA | PA | 19104 | 236434390 | 501(C)(3) | $100,000 | $0 | RESEARCH | |
| UNIVERSITY OF CALIFORNIA IRVINE | |||||||||
| 228 ALDRICH HALL | IRVINE | CA | 92697 | 952226406 | STATE OF CA | $100,000 | $0 | RESEARCH | |
| UNIVERSITY OF CALIFORNIA SAN FRANCISCO | |||||||||
| 1855 FOLSOM STREET SUITE 425 | SAN FRANCISCO | CA | 94103 | 946036493 | STATE OF CA | $100,000 | $0 | RESEARCH | |
| UNIVERSITY OF WASHINGTON | |||||||||
| 7425 FORSYTH BOULEVARD | SAINT LOUIS | MO | 63105 | 430653611 | 501(C)(3) | $100,000 | $0 | RESEARCH | MSC1299-414-355 |
| MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION | |||||||||
| 204 CRAFT AVENUE | PITTSBURGH | PA | 15213 | 251462312 | 501(C)(3) | $97,413 | $0 | RESEARCH | |
| STANFORD UNIVERSITY | |||||||||
| 485 BROADWAY MAIL CODE 8838 | REDWOOD CITY | CA | 94063 | 941156365 | 501(C)(3) | $75,000 | $0 | RESEARCH | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 18 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | OCRA MONITORS THE USE OF GRANT FUNDS BY REQUIRING ALL GRANTEES TO SUBMIT YEARLY FINANCIAL AND NARRATIVE PROGRESS REPORTS DETAILING THE USE OF FUNDS AND PROGRAM OUTCOMES. THESE REPORTS ARE REVIEWED BY OCRA TO CONFIRM COMPLIANCE WITH THE STATED CHARITABLE OBJECTIVES. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (1) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | 0 | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (7 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AUDRA L MORAN | ||||||||||||||
| PRESIDENT & CEO | $333,548 | $0 | $0 | $0 | $0 | $0 | $13,342 | $0 | $21,865 | $0 | $368,755 | $0 | $0 | $0 |
| JONATHAN ZEIDMAN | ||||||||||||||
| CHIEF DEVELOPMENT OFFICER | $201,949 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $43,479 | $0 | $245,428 | $0 | $0 | $0 |
| SARAH C DEFEO | ||||||||||||||
| CHIEF PROGRAM OFFICER | $171,149 | $0 | $0 | $0 | $0 | $0 | $7,839 | $0 | $62,037 | $0 | $241,025 | $0 | $0 | $0 |
| TRACY MOORE | ||||||||||||||
| VICE PRESIDENT, SUPPORT & EDUCATION | $162,573 | $0 | $0 | $0 | $0 | $0 | $6,503 | $0 | $21,712 | $0 | $190,788 | $0 | $0 | $0 |
| NICOLE WARGO | ||||||||||||||
| VP - PHILANTHROPIC PARTNER | $109,257 | $0 | $0 | $0 | $0 | $0 | $5,938 | $0 | $58,767 | $0 | $173,962 | $0 | $0 | $0 |
| BIBI ALI | ||||||||||||||
| FORMER CHIEF FINANCIAL OFFICER | $0 | $0 | $0 | $0 | $157,000 | $0 | $0 | $0 | $0 | $0 | $157,000 | $0 | $0 | $0 |
| CHAD RAMSEY | ||||||||||||||
| VICE PRESIDENT, POLICY | $126,974 | $0 | $0 | $0 | $0 | $0 | $5,079 | $0 | $21,612 | $0 | $153,665 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 4A | FormAndLineReferenceDesc |
| Explanation | OCRA MADE PAYMENTS TO THE FORMER CHIEF FINANCIAL OFFICER IN THE AMOUNT OF $157,000 IN 2025. THE AMOUNTS WERE TREATED AS TAXABLE COMPENSATION TO THE RECIPIENT AND REPORTED IN PART II, COLUMN (B)(III). | ExplanationTxt |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 21 | ContributionCnt |
| Noncash Contributions Rpt F990 | $1,141,580 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | SALES PRICE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8283 Received | 0 | Form8283ReceivedCnt |
| Any Property That Must Be Held | 0 | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (1) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | 0 | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, COLUMN (B): | FormAndLineReferenceDesc |
| Explanation | THE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTORS IN PART I, COLUMN (B) OF SCHEDULE M. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (6 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART I, ITEM C | DBA: OVARIAN CANCER RESEARCH ALLIANCE DBA: THE EDMEE FIRTH FUND FOR RESEARCH ON OVARIAN CANCER DBA: THE EDMEE FIRTH FUND FOR RESEARCH IN OVARIAN CANCER |
| FORM 990, PART VI, SECTION B, LINE 11B | THE FORM 990 IS PROVIDED TO THE BOARD OF DIRECTORS, AUDIT COMMITTEE, TREASURER, AND THE CEO, AND IS REVIEWED WITH THE EXTERNAL CPA PRIOR TO ITS FILING WITH THE IRS. |
| FORM 990, PART VI, SECTION B, LINE 12C | OCRA'S CONFLICT OF INTEREST POLICY (THE "POLICY") APPLIES TO DIRECTORS, OFFICERS AND OTHER EMPLOYEES OR OTHER PERSONS IN A POSITION TO INFLUENCE POLICY OR EXPENDITURES ("KEY PERSONS") WHO ARE ANNUALLY PROVIDED A COPY OF THE POLICY. THE POLICY INCLUDES A REPORTING FORM FOR EXISTING OR POTENTIAL CONFLICTS, AND EACH KEY PERSON IS REQUIRED TO COMPLETE ANNUALLY THE REPORTING FORM. IN CONNECTION WITH ANY PROPOSED TRANSACTION OR ARRANGEMENT BETWEEN OCRA AND ANY SUCH KEY PERSON OR RELATED PERSONS OR ENTITIES THAT RAISES AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST, THE KEY PERSON MUST DISCLOSE THE EXISTENCE AND NATURE OF HIS OR HER RELATIONSHIP AND FINANCIAL INTEREST TO THE PRESIDENT OR THE CHAIR OR CO-CHAIR OF THE BOARD OF DIRECTORS OR THE CHAIR OF ANY AUTHORIZED COMMITTEE. THE POLICY PROVIDES FOR CONSIDERATION OF ANY SUCH TRANSACTION OR ARRANGEMENT BY BOARD OR COMMITTEE MEMBERS BY FOLLOWING CERTAIN MEETING, DISCUSSION, VOTING AND DOCUMENTATION PROCEDURES. OTHER THAN TO PROVIDE INFORMATION OR RESPOND TO QUESTIONS, THE KEY PERSON IS EXCLUDED FROM THE DISCUSSION AND THE DECISION OF WHETHER A CONFLICT OF INTEREST EXISTS. |
| FORM 990, PART VI, SECTION B, LINE 15 | OCRA HAS A COMPENSATION COMMITTEE WHICH MEETS ANNUALLY TO REVIEW THE COMPENSATION OF THE CEO. THE COMPENSATION COMMITTEE DETERMINES THE CEO'S COMPENSATION BY UTILIZING DATA FROM COMPARABLY-SIZED ORGANIZATIONS (OBTAINED FORM 990 FILINGS). THE COMPENSATION DECISION IS DOCUMENTED IN THE RECORDS OF THE ORGANIZATION. SALARY INCREASES FOR KEY EMPLOYEES ARE RECOMMENDED BY THE CEO TO THE COMPENSATION COMMITTEE AFTER AN ANNUAL EVALUATION IS COMPLETED. THE COMPENSATION DECISION IS DOCUMENTED IN THE RECORDS OF THE ORGANIZATION. |
| FORM 990, PART VI, SECTION C, LINE 19 | FINANCIAL STATEMENTS ARE AVAILABLE ON OCRA'S WEBSITE. ALL OTHER DOCUMENTS ARE AVAILABLE UPON REQUEST. |
| FORM 990, PART XI, LINE 9: | GRANT REFUNDS 262,392. |
Schedule R IRS990ScheduleR
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | OVARIAN CANCER NATIONAL ALLIANCE | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1101 14TH STREET NW SUITE 850 | AddressLine1Txt |
| City | WASHINGTON | CityNm |
| State Abbreviation | DC | StateAbbreviationCd |
| ZIP | 20005 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 311581756 | EIN |
| Primary Activities | EDUCATION AND ADVOCACY | PrimaryActivitiesTxt |
| Legal Domicile State | DC | LegalDomicileStateCd |
| Exempt Code Section | 501(C)(3) | ExemptCodeSectionTxt |
| Public Charity Status | LINE 10 | PublicCharityStatusTxt |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | THE OVARIAN CANCER RESEARCH FUND INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Controlled Organization | Yes (1) | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | 0 | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | 0 | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | 0 | SharingOfFacilitiesInd |
| Paid Employees Sharing | 0 | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | 0 | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Comments